<bill session="116" type="h" number="2855" updated="2019-09-05T21:47:46Z">
  <state datetime="2019-05-20">REFERRED</state>
  <status>
    <introduced datetime="2019-05-20"/>
  </status>
  <introduced datetime="2019-05-20"/>
  <titles>
    <title type="official" as="introduced">To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.</title>
    <title type="display">To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.</title>
  </titles>
  <sponsor bioguide_id="K000362"/>
  <cosponsors/>
  <actions>
    <action datetime="2019-05-20">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-05-20" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Private Legislation"/>
  </subjects>
  <amendments/>
  <summary date="2019-05-20T04:00:00Z" status="Introduced in House">This bill provides for approval of the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides.</summary>
  <committee-reports/>
</bill>
